Zhongchao Inc Cl A (ZCMD)

2026-06-26T23:50:36.000Z - 2 days ago

Zhongchao Inc trading halted, news pending

2026-06-25T12:05:28.000Z - 4 days ago

Zhongchao implements 1-for-3 share consolidation

Jun 25, 2026, 8:00 AM EDT - 4 days ago

Zhongchao Inc. Announces 1-for-3 Share Consolidation

2026-06-05T23:51:00.000Z - 23 days ago

Zhongchao Inc trading halted, news pending

2026-06-04T12:07:42.000Z - 25 days ago

Zhongchao implements 1-for-31 share consolidation

Jun 4, 2026, 8:00 AM EDT - 25 days ago

Zhongchao Inc. Announces 1-for-31 Share Consolidation

2026-05-29T14:31:23.000Z - 4 weeks ago

Zhongchao 9.26M share Spot Secondary priced at $0.54

May 29, 2026, 10:00 AM EDT - 4 weeks ago

Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering

2026-05-07T22:02:52.000Z - 7 weeks ago

Zhongchao files to sell 5.56M units

2026-02-28T00:50:11.000Z - 4 months ago

Zhongchao Inc trading halted, news pending

2026-02-26T13:49:00.000Z - 4 months ago

Zhongchao announces 1-for-8 share consolidation

Feb 26, 2026, 8:30 AM EST - 4 months ago

Zhongchao Inc. Announces 1-for-8 Share Consolidation

2024-05-23T20:07:23.000Z - 2 years ago

Zhongchao files $300M mixed securities shelf

Mar 12, 2024, 8:30 AM EDT - 2 years ago

Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications

2024-02-29T00:50:09.000Z - 2 years ago

Zhongchao Inc trading halted, news pending

2024-02-27T13:09:49.000Z - 2 years ago

Zhongchao announces 1-for-10 share consolidation

Feb 27, 2024, 8:00 AM EST - 2 years ago

Zhongchao Inc. Announces 1-for-10 Share Consolidation

2023-12-11T13:06:39.000Z - 2 years ago

Zhongchao collaborates with health foundation to support cancer treatment

Dec 11, 2023, 8:00 AM EST - 2 years ago

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

Oct 23, 2023, 8:00 AM EDT - 2 years ago

Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day

Sep 25, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Aug 24, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management

Jul 11, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education

Jun 12, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment

May 12, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Announces Strategic Cooperation with Ximalaya

May 8, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China

2023-04-24T12:05:40.000Z - 3 years ago

Zhongchao partners with public health foundation for cancer patient health

Apr 24, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' Health

Mar 30, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform

Mar 13, 2023, 8:00 AM EDT - 3 years ago

Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction

2023-02-23T13:10:27.000Z - 3 years ago

Zhongchao renews partnership with Johnson & Johnson China

JNJ

Feb 23, 2023, 8:00 AM EST - 3 years ago

Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)

2023-02-13T14:22:50.000Z - 3 years ago

Zhongchao’s MDMOOC Platform to apply ChatGPT technology

Feb 13, 2023, 9:20 AM EST - 3 years ago

Zhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment Efficiency

Feb 8, 2023, 7:30 AM EST - 3 years ago

Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience

Jan 31, 2023, 7:30 AM EST - 3 years ago

Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China

Jan 19, 2023, 7:30 AM EST - 3 years ago

Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment

2023-01-04T12:35:25.000Z - 3 years ago

Zhongchao: Xinjiang Pharmaceutical to distribute drugs of Natco Pharma in China

Jan 4, 2023, 7:30 AM EST - 3 years ago

Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited

Dec 5, 2022, 7:30 AM EST - 3 years ago

Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform

Nov 3, 2022, 7:30 AM EDT - 3 years ago

Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market

Sep 28, 2022, 9:18 AM EDT - 4 years ago

Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications

Sep 15, 2022, 7:30 AM EDT - 4 years ago

Zhongchao Inc. Establishes Zhixun Internet Hospital to Provide Patient with Management Services Focusing on the Oncology and Other Major Diseases

Sep 1, 2022, 7:30 AM EDT - 4 years ago

Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management

Jun 13, 2022, 6:30 AM EDT - 4 years ago

Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management Course

May 9, 2022, 6:30 AM EDT - 4 years ago

Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results

Oct 29, 2021, 6:30 AM EDT - 5 years ago

Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment

Sep 17, 2021, 6:30 AM EDT - 5 years ago

Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment

Sep 10, 2021, 6:30 AM EDT - 5 years ago

Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market

Aug 12, 2021, 8:30 AM EDT - 5 years ago

Zhongchao Inc. Builds A Patient DOT Management System

Jul 27, 2021, 8:30 AM EDT - 5 years ago

Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level

Jul 1, 2021, 8:30 AM EDT - 5 years ago

Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management

May 28, 2021, 6:30 AM EDT - 5 years ago

Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management

Apr 30, 2021, 9:00 AM EDT - 5 years ago

Zhongchao Inc. Reports the Fiscal Year 2020 Financial Results

Mar 17, 2021, 6:30 AM EDT - 5 years ago

Zhongchao Renews Contract with China Association of Health Promotion and Education and GlaxoSmithKline

Jan 13, 2021, 6:30 AM EST - 5 years ago

Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts

Dec 10, 2020, 8:53 AM EST - 6 years ago

6 Health Care Stocks Trading With Low Price-Earnings Ratios

YCBD

Nov 12, 2020, 6:30 AM EST - 6 years ago

Zhongchao Inc. and Takeda Pharmaceutical Expand Scope of Cooperation in China

Sep 21, 2020, 9:15 AM EDT - 6 years ago

Zhongchao Inc. Reports the First Half of Fiscal Year 2020 Financial Results